Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
Mehregan Babamohamadi, Nastaran Keshavarz Mohammadi, Elham Faryadi, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Regulation of Treg cells by cytokine signaling and co-stimulatory molecules
Yuan Zong, Kaihang Deng, Wai Po Chong
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 30
Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy
Rose Ghemrawi, Lama Abuamer, Sedra Kremesh, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2158-2158
Open Access | Times Cited: 12
Promising Therapeutic Strategies for Hematologic Malignancies: Innovations and Potential
Jan Jakub Lica, Bhaskar Pradhan, Kawthar Safi, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 4280-4280
Open Access | Times Cited: 7
Natural Alkaloids in Cancer Therapy: Berberine, Sanguinarine and Chelerythrine against Colorectal and Gastric Cancer
Anna Duda-Madej, Szymon Viscardi, W. Szewczyk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8375-8375
Open Access | Times Cited: 6
Single domain antibody: Development and application in biotechnology and biopharma
Ting Yu, Fang Zheng, Wenbo He, et al.
Immunological Reviews (2024)
Open Access | Times Cited: 5
Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges
A. Raja, Abhishek Kasana, Vaishali Verma
Molecular Biotechnology (2024)
Closed Access | Times Cited: 5
Design, and Evaluation of In-Silico Anti-cancer Activity of Novel Gefitinib Analogues Against 21 Target Proteins
Supriti Khan Ushna, Ananta Kumar Das
Deleted Journal (2025), pp. 100030-100030
Closed Access
Diagnosis and treatment of lung cancer: A molecular perspective
Yuan Xiong, Long Cheng, Yujie Zhou, et al.
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 3
Closed Access
Peptide‑based therapeutic strategies for glioma: current state and prospects
Yajing Mi, Pengtao Jiang, Jing Luan, et al.
Peptides (2025) Vol. 185, pp. 171354-171354
Closed Access
Research trends in the use of nanobodies for cancer therapy
Jun Hou, Kun Du, Jinling Li, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113454-113454
Closed Access
Post-translational modifications in hepatocellular carcinoma: unlocking new frontiers in immunotherapy
Yuexian Piao, Naicui Zhai, Xiaoling Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Unmasking the potential: mechanisms of neuroinflammatory modulation by oncolytic viruses in glioblastoma
Narimene Beder, Seyedeh Nasim Mirbahari, Mourad Belkhelfa, et al.
Exploration of Targeted Anti-tumor Therapy (2025)
Open Access
Exploring radiation resistance-related genes in pancreatic cancer and their impact on patient prognosis and treatment
Dong Dai, Sen Wang, J. Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Recent advances in oncolytic virus combined immunotherapy in tumor treatment
Xiaoli Zhou, Shunfeng Hu, Xin Wang
Genes & Diseases (2025), pp. 101599-101599
Open Access
Therapeutic effects of NK cell-derived EVs on cancer: Current advances and future treatment strategies
Mehtap Kızılpınar, Mohammadreza Dastourı
(2025) Vol. 2, Iss. 1, pp. 10-24
Closed Access
Challenges and opportunities in single-domain antibody-based tumor immunotherapy
Xiaozhi Xi, Guo Shu-hua, Yuchao Gu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189284-189284
Closed Access
Molecular Mechanisms of Immune Regulation: A Review
Borros Arneth
Cells (2025) Vol. 14, Iss. 4, pp. 283-283
Open Access
Chronic High-Salt Diet Activates Tumor-Initiating Stem Cells Leading to Breast Cancer Proliferation
Lisa Tucker, Umer Ali, Roy Zent, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 912-912
Open Access | Times Cited: 3
Nivolumab and Ipilimumab Acting as Tormentors of Advanced Tumors by Unleashing Immune Cells and Associated Collateral Damage
Bushra Khan, Rowaid Qahwaji, Mashael S. Alfaifi, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 732-732
Open Access | Times Cited: 1
Advances in immunotherapy for mucosal melanoma: harnessing immune checkpoint inhibitors for improved treatment outcomes
Zexing Shan, Fei Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Prognostic implication of CD47 and CTLA-4 expressions in endometrial carcinoma
Mona M. Ahmed, Samia Hussein, Mohamed AbdAlsalam, et al.
Human Immunology (2024) Vol. 86, Iss. 1, pp. 111210-111210
Closed Access | Times Cited: 1
Clinical applications and perspectives of immune checkpoint inhibitors in oral squamous cell carcinoma
Liuyu Ru, Jiwei Zheng
ONCOLOGIE (2024) Vol. 26, Iss. 4, pp. 535-547
Open Access
Nanobody immunolabelling and three-dimensional imaging reveals spatially restricted LYVE1 expression by kidney lymphatic vessels in mice
E. M. Funk, Daniyal J. Jafree, Nils Rouven Hansmeier, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Monoclonal Antibody Therapies in Cancer Immunotherapy
Charuwan Thanawiroon, Bancha Yingngam
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 419-472
Closed Access
The potential immunotherapy effect of Ginkgolide B thwarts oral squamous cell carcinoma progression by targeting the SREBP1/KLK8/CCL22 axis
De-Wei Lai, Pei‐Yi Chu, Meei‐Ling Sheu, et al.
Phytomedicine (2024) Vol. 136, pp. 156249-156249
Closed Access
Page 1 - Next Page

Scroll to top